Company CVAbout Trinity League India Ltd 
Trinity League India Ltd
Micro Cap
Pharmaceuticals & Drugs
Trinity League India Ltd. (formerly known Dr. Wellman's Homoeopathic Laboratory Ltd) was incorporated as a private limited company in 1988 and became a public limited company in Feb.'95. The company was promoted by Gurmeet Singh Dhingra. Presently, it is engaged in manufacture of homoeopathic medicines, health care products and herbal hair care products. The company's manufacturing facilities are located at its two units in Delhi.
Company Coordinates
Company Details
A-23 Mandakini Enclave, Alaknanda G K II New Delhi New Delhi : 110019
Registrar Details
Beetal Financial & Computer Services (P) Ltd , Beetal House , 99 Mandangir, 3rd Floor, Behind Local Shopping Centre, Near Dada Harsukhdas Mandir, New Delhi
Capital StructureCapital Structure
Present Equity Capital
INR 5.07 Cr
Number of Shares
50.67 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
01-Jun-2016
50.67
5.07
191200
10
Reissue of Forfeited Shares
23-Jul-2015
48.76
4.88
180000
10
Reissue of Forfeited Shares
30-Sep-2013
46.96
4.70
220000
10
Unspecified
30-Sep-2013
46.96
4.70
220000
10
Unspecified
30-Jun-2012
44.76
4.48
-591200
10
Forfeited Shares
30-Jun-2012
44.76
4.48
-591200
10
Forfeited Shares
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Devinder Kumar Jain (41.54%)
Highest Public shareholder
Vijay Malhotra (2.38%)
Individual Investors Holdings
35.02%
Board of Directors
Management
Designation
Remuneration
D K Jain
Chairman & Managing Director
0
Madhulika Jain
Director
0
Shashank Chandhok
Independent Director
25.0 k
Piyush Kumar Srivatsava
Company Sec. & Compli. Officer
5.71 lacs
Neeraj Jha
Independent Director
5.0 k
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Risk Management & Consultancy Income
0.85
100.00%
Risk Management & Consultancy Income
Stock DNARevenue and Profits:
Net Sales:
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
Pharmaceuticals & Drugs
INR 10 Cr (Micro Cap)
NA (Loss Making)
33
0.00%
-0.01
-64.44%
3.52
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
